Gland Pharma Limited

NSE:GLAND.NS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

India

Market Cap

USD 3.87 B

Share Price

USD 23.60

Avg Daily Volume

279,353

Change (1 day)

0.46%

Change (1 year)

-7.71%

Change (YTD)

13.56%

Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2025: USD 107.04 M

Gland Pharma Limited Operating Cash Flow is USD 107.04 M for the year ending March 31, 2025, a -10.43% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2024 was USD 119.51 M, a 169.86% change year over year.
Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2023 was USD 44.28 M, a -57.48% change year over year.
Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2022 was USD 104.14 M, a 26.06% change year over year.
Gland Pharma Limited Operating Cash Flow for the year ending March 31, 2021 was USD 82.62 M, a -11.18% change year over year.